| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Matinas Biopharma Holdings, Inc. (MTNB) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. MTNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2019 | Lepore Patrick G | Director | Buy | 100,000 | $0.72 | $71,850.00 | +100.0% | |
| Jun 14, 2019 | Stern Adam K | Director | Buy | 15,000 | $0.80 | $12,000.00 | +0.5% | |
| Jun 12, 2019 | Jabbour Jerome D | President And CEO | Buy | 12,487 | $0.80 | $9,979.61 | +1.6% | |
| Jun 12, 2019 | Stern Adam K | Director | Buy | 20,000 | $0.80 | $15,998.00 | +0.6% | |
| Jun 10, 2019 | Stern Adam K | Director | Buy | 15,000 | $0.82 | $12,300.00 | +0.5% | |
| Jun 7, 2019 | Stern Adam K | Director | Buy | 20,000 | $0.89 | $17,800.00 | +0.6% | |
| May 31, 2019 | Stern Adam K | Director | Buy | 80,000 | $0.94 | $75,200.00 | +2.6% | |
| May 16, 2019 | Conrad Herbert J | Director | Buy | 25,000 | $0.96 | $24,115.00 | +16.9% | |
| May 16, 2019 | Lepore Patrick G | Director | Buy | 100,000 | $0.95 | $95,250.00 | New | |
| May 16, 2019 | Stern Adam K | Director | Buy | 150,000 | $0.95 | $142,500.00 | +5.1% |